Pharma News
-
3t Energy Group launches world’s most technologically advanced platform
Pharma | News | 0 Comment | 04 Aug, 2020
The world’s most technologically advanced, cloud-based workforce management and training platform Transform is bei...Read more
-
Sanofi, GSK to supply up to 300 M COVID-19 vaccine doses to EU
Pharma | News | 0 Comment | 05 Aug, 2020
Sanofi and GSK are in advanced discussions, with the European Commission (EC) for the supply of up to 300 million doses ...Read more
-
COVID R&D Alliance announces first patients enrollment in I-SPY trial
Pharma | News | 0 Comment | 04 Aug, 2020
Recently, members of the COVID R&D Alliance AbbVie, Inc. (ABBV), Amgen Inc. (AMGN), and Takeda Pharmaceutical Co. Lt...Read more
-
PharmAbcine, SLBio to evaluate combination therapy to treat NSCLC
Pharma | News | 0 Comment | 05 Aug, 2020
South Korean firm PharmAbcine Inc. entered into a research collaboration with Wuxi Shuangliang Biotechnology (SLBio) to ...Read more
-
G1, Simcere to bring new cancer therapy in Greater China
Pharma | News | 0 Comment | 06 Aug, 2020
US based G1 Therapeutics, Inc., a clinical-stage oncology company, and Simcere Pharmaceutical Group, a pharmaceutic...Read more
-
Takeda announces results for first quarter of fiscal 2020
Pharma | News | 0 Comment | 03 Aug, 2020
Japan-based Takeda Pharmaceutical Company Limited (Takeda) recently announced financial results for the first quarter of...Read more
-
Takeda receives U.S. FDA Breakthrough Therapy Designation for Pevonedistat
Pharma | News | 0 Comment | 30 Jul, 2020
Takeda Pharmaceutical Company Limited on 30 July 2020 announced that the U.S. Food and Drug Administration (FD...Read more
-
Innovent announces first patient dosed in Ph 1 clinical trial of bispecific antibody
Pharma | News | 0 Comment | 03 Aug, 2020
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical Chinese company that develops, manufactures and com...Read more
-
Novartis to strengthen future of antibiotics manufacturing in Europe
Pharma | News | 0 Comment | 04 Aug, 2020
Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together wi...Read more
-
J&J to commence Ph III trial of COVID-19 vaccine in Sept
Pharma | News | 0 Comment | 03 Aug, 2020
American multinational corporation Johnson & Johnson (J&J) has announced that its lead vaccine candidate pr...Read more
-
Hisun's Favipiravir supports Middle East in fighting COVID-19
Pharma | News | 0 Comment | 31 Jul, 2020
According to the Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown exc...Read more
-
Henlius & Accord Healthcare receives EMA approval for Zercepac®
Pharma | News | 0 Comment | 30 Jul, 2020
The European Commission (EC) has approved Shanghai-based Henlius Biotech, Inc. and Accord Healthcare Limited (Accor...Read more
-
Austrianova files Drug Master File with FDA for Cell-in-a-Box products from HEK293 cells
Pharma | News | 0 Comment | 28 Jul, 2020
S.E. Asian company, Austrianova, headquartered in Singapore, announced on 28 July 2020 that it has filed a Drug Mas...Read more
-
A strong signal in turbulent times: Vetter achieves carbon dioxide-neutral levels
Pharma | News | 0 Comment | 29 Jul, 2020
Focus on energy-efficient and environmentally friendly technology All European sites utilize green electricity Savin...Read more
-
Dynavax, Medigen to develop adjuvanted COVID-19 vaccine candidate
Pharma | News | 0 Comment | 30 Jul, 2020
US based Dynavax Technologies Corporation, a biopharmaceutical company focused on developing and commercializing novel v...Read more
-
Novavax, Fujifilm to manufacture COVID-19 vaccine at large scale
Pharma | News | 0 Comment | 30 Jul, 2020
US based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious di...Read more
-
Henlius, Accord receive EMA approval for Zercepac®, trastuzumab biosimilar
Pharma | News | 0 Comment | 29 Jul, 2020
Shanghai Henlius Biotech, Inc. announced that Marketing Authorization Application (“MAA”) for HLX02 (trastuz...Read more
-
Foresee announces submission of NDA for FDA approval of LMIS 50 mg
Pharma | News | 0 Comment | 29 Jul, 2020
Taiwan and US-based biopharmaceutical company, Foresee Pharmaceuticals Co., Ltd. (Foresee), recently announced that...Read more
